CG
Therapeutic Areas
Ymmunobio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Bispecific T-Cell Engager (BiTCE) | NPTXR+ Solid Tumors | Preclinical |
| Radiopharmaceutical (RPT-Dx/Tx) | NPTXR+ Solid Tumors (Imaging & Therapy) | Preclinical |
| Dual-payload Antibody-Drug Conjugate (ADC) | NPTXR+ Solid Tumors | Preclinical |
| CAR-T Cell Therapy | NPTXR+ Solid Tumors | Preclinical |